Type 2 Diabetes Diabetes Cardiovascular Disease Fatty Liver Disease Gestational Diabetes Dental Health Pharmacological Advances Epigenetics Diet-induced Obesity
Durable Exendin-4 secretion without detectable off-target edits or liver toxicity suggests a one-time genome editing therapy for obesity